SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'RTL'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1AQB_A_RTLA185_0 (RETINOL-BINDINGPROTEIN) |
1iiu | PLASMARETINOL-BINDINGPROTEIN (Gallusgallus) | 10 / 10 | LEU A 35ALA A 55VAL A 61MET A 73MET A 88TYR A 90LEU A 97GLN A 98HIS A 104PHE A 135 | RTL A 176 (-4.5A)RTL A 176 ( 3.8A)NoneRTL A 176 ( 4.0A)RTL A 176 (-3.4A)RTL A 176 ( 4.0A)RTL A 176 (-4.0A)RTL A 176 (-3.8A)RTL A 176 ( 4.7A)RTL A 176 ( 4.2A) | 0.36A | 1aqbA-1iiuA:32.8 | 1aqbA-1iiuA:80.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1BRP_A_RTLA183_0 (RETINOL BINDINGPROTEIN) |
1iiu | PLASMARETINOL-BINDINGPROTEIN (Gallusgallus) | 5 / 12 | ALA A 43PHE A 77MET A 88HIS A 104PHE A 135 | RTL A 176 ( 4.1A)NoneRTL A 176 (-3.4A)RTL A 176 ( 4.7A)RTL A 176 ( 4.2A) | 1.00A | 1brpA-1iiuA:31.3 | 1brpA-1iiuA:84.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1BRP_A_RTLA183_0 (RETINOL BINDINGPROTEIN) |
1iiu | PLASMARETINOL-BINDINGPROTEIN (Gallusgallus) | 5 / 12 | ALA A 57GLY A 75PHE A 77MET A 88PHE A 137 | RTL A 176 ( 3.8A)RTL A 176 ( 4.0A)NoneRTL A 176 (-3.4A)None | 1.16A | 1brpA-1iiuA:31.3 | 1brpA-1iiuA:84.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1BRP_A_RTLA183_0 (RETINOL BINDINGPROTEIN) |
1iiu | PLASMARETINOL-BINDINGPROTEIN (Gallusgallus) | 6 / 12 | LEU A 37ALA A 57MET A 73LEU A 97GLN A 98HIS A 117 | RTL A 176 ( 4.5A)RTL A 176 ( 3.8A)RTL A 176 ( 4.0A)RTL A 176 (-4.0A)RTL A 176 (-3.8A)RTL A 176 ( 4.6A) | 1.33A | 1brpA-1iiuA:31.3 | 1brpA-1iiuA:84.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1BRP_A_RTLA183_0 (RETINOL BINDINGPROTEIN) |
1iiu | PLASMARETINOL-BINDINGPROTEIN (Gallusgallus) | 5 / 12 | LEU A 37MET A 73PHE A 45LEU A 97PHE A 135 | RTL A 176 ( 4.5A)RTL A 176 ( 4.0A)RTL A 176 ( 4.8A)RTL A 176 (-4.0A)RTL A 176 ( 4.2A) | 1.20A | 1brpA-1iiuA:31.3 | 1brpA-1iiuA:84.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1BRP_A_RTLA183_0 (RETINOL BINDINGPROTEIN) |
1iiu | PLASMARETINOL-BINDINGPROTEIN (Gallusgallus) | 12 / 12 | LEU A 37PHE A 45ALA A 57MET A 73GLY A 75PHE A 77MET A 88TYR A 90LEU A 97GLN A 98HIS A 104PHE A 135 | RTL A 176 ( 4.5A)RTL A 176 ( 4.8A)RTL A 176 ( 3.8A)RTL A 176 ( 4.0A)RTL A 176 ( 4.0A)NoneRTL A 176 (-3.4A)RTL A 176 ( 4.0A)RTL A 176 (-4.0A)RTL A 176 (-3.8A)RTL A 176 ( 4.7A)RTL A 176 ( 4.2A) | 0.33A | 1brpA-1iiuA:31.3 | 1brpA-1iiuA:84.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1CRB_A_RTLA200_0 (CELLULAR RETINOLBINDING PROTEIN) |
1mx8 | CELLULARRETINOL-BINDINGPROTEIN I, HOLO (Rattusnorvegicus) | 8 / 12 | PHE A 16ALA A 33LEU A 36ILE A 51THR A 53ARG A 58MET A 62ILE A 77 | RTL A 135 ( 4.6A)RTL A 135 ( 3.9A)RTL A 135 ( 4.6A)RTL A 135 ( 4.6A)RTL A 135 ( 4.3A)NoneRTL A 135 (-2.9A)RTL A 135 (-3.5A) | 1.01A | 1crbA-1mx8A:20.4 | 1crbA-1mx8A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1CRB_A_RTLA200_0 (CELLULAR RETINOLBINDING PROTEIN) |
1mx8 | CELLULARRETINOL-BINDINGPROTEIN I, HOLO (Rattusnorvegicus) | 8 / 12 | PHE A 16ALA A 33LEU A 36LYS A 40ILE A 51ARG A 58MET A 62ILE A 77 | RTL A 135 ( 4.6A)RTL A 135 ( 3.9A)RTL A 135 ( 4.6A)RTL A 135 ( 4.4A)RTL A 135 ( 4.6A)NoneRTL A 135 (-2.9A)RTL A 135 (-3.5A) | 0.95A | 1crbA-1mx8A:20.4 | 1crbA-1mx8A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1CRB_A_RTLA200_0 (CELLULAR RETINOLBINDING PROTEIN) |
1mx8 | CELLULARRETINOL-BINDINGPROTEIN I, HOLO (Rattusnorvegicus) | 7 / 12 | PHE A 16LEU A 20LEU A 29ALA A 33LEU A 36LYS A 40ILE A 51 | RTL A 135 ( 4.6A)RTL A 135 ( 4.7A)RTL A 135 (-3.8A)RTL A 135 ( 3.9A)RTL A 135 ( 4.6A)RTL A 135 ( 4.4A)RTL A 135 ( 4.6A) | 0.78A | 1crbA-1mx8A:20.4 | 1crbA-1mx8A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1CRB_A_RTLA200_0 (CELLULAR RETINOLBINDING PROTEIN) |
1mx8 | CELLULARRETINOL-BINDINGPROTEIN I, HOLO (Rattusnorvegicus) | 8 / 12 | PHE A 16LEU A 29ALA A 33LEU A 36ILE A 51THR A 53MET A 62ILE A 77 | RTL A 135 ( 4.6A)RTL A 135 (-3.8A)RTL A 135 ( 3.9A)RTL A 135 ( 4.6A)RTL A 135 ( 4.6A)RTL A 135 ( 4.3A)RTL A 135 (-2.9A)RTL A 135 (-3.5A) | 0.95A | 1crbA-1mx8A:20.4 | 1crbA-1mx8A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1CRB_A_RTLA200_0 (CELLULAR RETINOLBINDING PROTEIN) |
1mx8 | CELLULARRETINOL-BINDINGPROTEIN I, HOLO (Rattusnorvegicus) | 8 / 12 | PHE A 16LEU A 29ALA A 33LEU A 36LYS A 40ILE A 51MET A 62ILE A 77 | RTL A 135 ( 4.6A)RTL A 135 (-3.8A)RTL A 135 ( 3.9A)RTL A 135 ( 4.6A)RTL A 135 ( 4.4A)RTL A 135 ( 4.6A)RTL A 135 (-2.9A)RTL A 135 (-3.5A) | 0.92A | 1crbA-1mx8A:20.4 | 1crbA-1mx8A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FEM_A_REAA184_1 (RETINOL BINDINGPROTEIN) |
1iiu | PLASMARETINOL-BINDINGPROTEIN (Gallusgallus) | 5 / 10 | VAL A 61MET A 73LEU A 97GLN A 98HIS A 117 | NoneRTL A 176 ( 4.0A)RTL A 176 (-4.0A)RTL A 176 (-3.8A)RTL A 176 ( 4.6A) | 1.38A | 1femA-1iiuA:22.7 | 1femA-1iiuA:79.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FEM_A_REAA184_1 (RETINOL BINDINGPROTEIN) |
1iiu | PLASMARETINOL-BINDINGPROTEIN (Gallusgallus) | 9 / 10 | VAL A 61MET A 73PHE A 77MET A 88TYR A 90LEU A 97GLN A 98HIS A 104TYR A 133 | NoneRTL A 176 ( 4.0A)NoneRTL A 176 (-3.4A)RTL A 176 ( 4.0A)RTL A 176 (-4.0A)RTL A 176 (-3.8A)RTL A 176 ( 4.7A)None | 0.50A | 1femA-1iiuA:22.7 | 1femA-1iiuA:79.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FMJ_A_RTLA401_0 (RETINOL DEHYDRATASE) |
1fml | RETINOL DEHYDRATASE (Spodopterafrugiperda) | 6 / 11 | LEU A 139SER A 142LYS A 162MET A 295ILE A 301PHE A 310 | NoneRTL A 401 (-3.2A)RTL A 401 (-2.6A)RTL A 401 ( 4.0A)NoneRTL A 401 (-4.3A) | 1.48A | 1fmjA-1fmlA:56.6 | 1fmjA-1fmlA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FMJ_A_RTLA401_0 (RETINOL DEHYDRATASE) |
1fml | RETINOL DEHYDRATASE (Spodopterafrugiperda) | 11 / 11 | TYR A 105TYR A 112TYR A 120LEU A 139SER A 142LYS A 162HIS A 164HIS A 197MET A 295ILE A 303PHE A 310 | RTL A 401 (-4.6A)RTL A 401 ( 4.8A)RTL A 401 ( 4.5A)NoneRTL A 401 (-3.2A)RTL A 401 (-2.6A)RTL A 401 (-4.4A)RTL A 401 (-4.2A)RTL A 401 ( 4.0A)RTL A 401 ( 4.0A)RTL A 401 (-4.3A) | 0.25A | 1fmjA-1fmlA:56.6 | 1fmjA-1fmlA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FMJ_B_RTLB501_0 (RETINOL DEHYDRATASE) |
1fml | RETINOL DEHYDRATASE (Spodopterafrugiperda) | 10 / 10 | TYR A 105TYR A 112TYR A 120LEU A 139SER A 142LYS A 162HIS A 164HIS A 197MET A 295ILE A 303 | RTL A 401 (-4.6A)RTL A 401 ( 4.8A)RTL A 401 ( 4.5A)NoneRTL A 401 (-3.2A)RTL A 401 (-2.6A)RTL A 401 (-4.4A)RTL A 401 (-4.2A)RTL A 401 ( 4.0A)RTL A 401 ( 4.0A) | 0.29A | 1fmjB-1fmlA:56.9 | 1fmjB-1fmlA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FML_A_RTLA401_0 (RETINOL DEHYDRATASE) |
1fml | RETINOL DEHYDRATASE (Spodopterafrugiperda) | 6 / 12 | LEU A 138LEU A 139SER A 142TYR A 298ILE A 301PHE A 310 | RTL A 401 ( 4.6A)NoneRTL A 401 (-3.2A)RTL A 401 (-4.2A)NoneRTL A 401 (-4.3A) | 1.33A | 1fmlA-1fmlA:60.1 | 1fmlA-1fmlA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FML_A_RTLA401_0 (RETINOL DEHYDRATASE) |
1fml | RETINOL DEHYDRATASE (Spodopterafrugiperda) | 12 / 12 | TYR A 105TYR A 112TYR A 120LEU A 138LEU A 139SER A 142HIS A 164HIS A 197LEU A 201TYR A 298ILE A 303PHE A 310 | RTL A 401 (-4.6A)RTL A 401 ( 4.8A)RTL A 401 ( 4.5A)RTL A 401 ( 4.6A)NoneRTL A 401 (-3.2A)RTL A 401 (-4.4A)RTL A 401 (-4.2A)RTL A 401 ( 4.3A)RTL A 401 (-4.2A)RTL A 401 ( 4.0A)RTL A 401 (-4.3A) | 0.00A | 1fmlA-1fmlA:60.1 | 1fmlA-1fmlA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FML_B_RTLB501_0 (RETINOL DEHYDRATASE) |
1fml | RETINOL DEHYDRATASE (Spodopterafrugiperda) | 12 / 12 | ILE A 111TYR A 112TYR A 120LEU A 138LEU A 139SER A 142HIS A 164HIS A 197LEU A 201TYR A 298ILE A 303PHE A 310 | RTL A 401 ( 4.9A)RTL A 401 ( 4.8A)RTL A 401 ( 4.5A)RTL A 401 ( 4.6A)NoneRTL A 401 (-3.2A)RTL A 401 (-4.4A)RTL A 401 (-4.2A)RTL A 401 ( 4.3A)RTL A 401 (-4.2A)RTL A 401 ( 4.0A)RTL A 401 (-4.3A) | 0.04A | 1fmlB-1fmlA:59.2 | 1fmlB-1fmlA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FML_B_RTLB501_0 (RETINOL DEHYDRATASE) |
1fml | RETINOL DEHYDRATASE (Spodopterafrugiperda) | 6 / 12 | LEU A 138LEU A 139SER A 142TYR A 298ILE A 301PHE A 310 | RTL A 401 ( 4.6A)NoneRTL A 401 (-3.2A)RTL A 401 (-4.2A)NoneRTL A 401 (-4.3A) | 1.34A | 1fmlB-1fmlA:59.2 | 1fmlB-1fmlA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1HBP_A_RTLA184_0 (RETINOL BINDINGPROTEIN) |
1iiu | PLASMARETINOL-BINDINGPROTEIN (Gallusgallus) | 6 / 11 | ALA A 57VAL A 61MET A 73LEU A 97GLN A 98HIS A 117 | RTL A 176 ( 3.8A)NoneRTL A 176 ( 4.0A)RTL A 176 (-4.0A)RTL A 176 (-3.8A)RTL A 176 ( 4.6A) | 1.32A | 1hbpA-1iiuA:32.2 | 1hbpA-1iiuA:79.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1HBP_A_RTLA184_0 (RETINOL BINDINGPROTEIN) |
1iiu | PLASMARETINOL-BINDINGPROTEIN (Gallusgallus) | 11 / 11 | LEU A 35PHE A 45ALA A 55ALA A 57VAL A 61MET A 73MET A 88TYR A 90LEU A 97GLN A 98HIS A 104 | RTL A 176 (-4.5A)RTL A 176 ( 4.8A)RTL A 176 ( 3.8A)RTL A 176 ( 3.8A)NoneRTL A 176 ( 4.0A)RTL A 176 (-3.4A)RTL A 176 ( 4.0A)RTL A 176 (-4.0A)RTL A 176 (-3.8A)RTL A 176 ( 4.7A) | 0.37A | 1hbpA-1iiuA:32.2 | 1hbpA-1iiuA:79.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1IIU_A_RTLA176_0 (PLASMARETINOL-BINDINGPROTEIN) |
1iiu | PLASMARETINOL-BINDINGPROTEIN (Gallusgallus) | 11 / 11 | LEU A 35LEU A 37ALA A 55ALA A 57MET A 73MET A 88TYR A 90LEU A 97GLN A 98HIS A 104ARG A 121 | RTL A 176 (-4.5A)RTL A 176 ( 4.5A)RTL A 176 ( 3.8A)RTL A 176 ( 3.8A)RTL A 176 ( 4.0A)RTL A 176 (-3.4A)RTL A 176 ( 4.0A)RTL A 176 (-4.0A)RTL A 176 (-3.8A)RTL A 176 ( 4.7A)RTL A 176 ( 4.8A) | 0.01A | 1iiuA-1iiuA:35.1 | 1iiuA-1iiuA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1IIU_A_RTLA176_0 (PLASMARETINOL-BINDINGPROTEIN) |
1iiu | PLASMARETINOL-BINDINGPROTEIN (Gallusgallus) | 5 / 11 | LEU A 37ALA A 57MET A 73LEU A 97HIS A 117 | RTL A 176 ( 4.5A)RTL A 176 ( 3.8A)RTL A 176 ( 4.0A)RTL A 176 (-4.0A)RTL A 176 ( 4.6A) | 1.26A | 1iiuA-1iiuA:35.1 | 1iiuA-1iiuA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1KGL_A_RTLA175_0 (CELLULARRETINOL-BINDINGPROTEIN TYPE I) |
1mx8 | CELLULARRETINOL-BINDINGPROTEIN I, HOLO (Rattusnorvegicus) | 6 / 12 | LEU A 29ALA A 33PRO A 38LYS A 40SER A 55ILE A 77 | RTL A 135 (-3.8A)RTL A 135 ( 3.9A)RTL A 135 ( 4.4A)RTL A 135 ( 4.4A)RTL A 135 ( 4.4A)RTL A 135 (-3.5A) | 1.13A | 1kglA-1mx8A:19.5 | 1kglA-1mx8A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1KGL_A_RTLA175_0 (CELLULARRETINOL-BINDINGPROTEIN TYPE I) |
1mx8 | CELLULARRETINOL-BINDINGPROTEIN I, HOLO (Rattusnorvegicus) | 7 / 12 | LEU A 29PRO A 38LYS A 40SER A 55TYR A 60GLY A 76ILE A 77 | RTL A 135 (-3.8A)RTL A 135 ( 4.4A)RTL A 135 ( 4.4A)RTL A 135 ( 4.4A)RTL A 135 ( 4.6A)RTL A 135 ( 4.9A)RTL A 135 (-3.5A) | 1.08A | 1kglA-1mx8A:19.5 | 1kglA-1mx8A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1KGL_A_RTLA175_0 (CELLULARRETINOL-BINDINGPROTEIN TYPE I) |
1mx8 | CELLULARRETINOL-BINDINGPROTEIN I, HOLO (Rattusnorvegicus) | 5 / 12 | PHE A 16ALA A 33LYS A 40SER A 55PHE A 57 | RTL A 135 ( 4.6A)RTL A 135 ( 3.9A)RTL A 135 ( 4.4A)RTL A 135 ( 4.4A)None | 1.27A | 1kglA-1mx8A:19.5 | 1kglA-1mx8A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1KGL_A_RTLA175_0 (CELLULARRETINOL-BINDINGPROTEIN TYPE I) |
1mx8 | CELLULARRETINOL-BINDINGPROTEIN I, HOLO (Rattusnorvegicus) | 6 / 12 | PHE A 16LEU A 29ALA A 33PRO A 38LYS A 40SER A 55 | RTL A 135 ( 4.6A)RTL A 135 (-3.8A)RTL A 135 ( 3.9A)RTL A 135 ( 4.4A)RTL A 135 ( 4.4A)RTL A 135 ( 4.4A) | 1.05A | 1kglA-1mx8A:19.5 | 1kglA-1mx8A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1KGL_A_RTLA175_1 (CELLULARRETINOL-BINDINGPROTEIN TYPE I) |
1mx8 | CELLULARRETINOL-BINDINGPROTEIN I, HOLO (Rattusnorvegicus) | 4 / 7 | LEU A 36ILE A 51THR A 53MET A 62 | RTL A 135 ( 4.6A)RTL A 135 ( 4.6A)RTL A 135 ( 4.3A)RTL A 135 (-2.9A) | 0.73A | 1kglA-1mx8A:19.5 | 1kglA-1mx8A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1KT3_A_RTLA184_0 (PLASMARETINOL-BINDINGPROTEIN) |
1iiu | PLASMARETINOL-BINDINGPROTEIN (Gallusgallus) | 7 / 7 | LEU A 35LEU A 37MET A 73MET A 88TYR A 90LEU A 97GLN A 98 | RTL A 176 (-4.5A)RTL A 176 ( 4.5A)RTL A 176 ( 4.0A)RTL A 176 (-3.4A)RTL A 176 ( 4.0A)RTL A 176 (-4.0A)RTL A 176 (-3.8A) | 0.40A | 1kt3A-1iiuA:28.1 | 1kt3A-1iiuA:79.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1KT4_A_RTLA184_0 (PLASMARETINOL-BINDINGPROTEIN) |
1iiu | PLASMARETINOL-BINDINGPROTEIN (Gallusgallus) | 5 / 12 | ALA A 55ALA A 43MET A 88HIS A 104TYR A 133 | RTL A 176 ( 3.8A)RTL A 176 ( 4.1A)RTL A 176 (-3.4A)RTL A 176 ( 4.7A)None | 1.15A | 1kt4A-1iiuA:31.6 | 1kt4A-1iiuA:79.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1KT4_A_RTLA184_0 (PLASMARETINOL-BINDINGPROTEIN) |
1iiu | PLASMARETINOL-BINDINGPROTEIN (Gallusgallus) | 12 / 12 | LEU A 35LEU A 37ALA A 55ALA A 57VAL A 61MET A 73MET A 88TYR A 90GLN A 98HIS A 104ARG A 121TYR A 133 | RTL A 176 (-4.5A)RTL A 176 ( 4.5A)RTL A 176 ( 3.8A)RTL A 176 ( 3.8A)NoneRTL A 176 ( 4.0A)RTL A 176 (-3.4A)RTL A 176 ( 4.0A)RTL A 176 (-3.8A)RTL A 176 ( 4.7A)RTL A 176 ( 4.8A)None | 0.33A | 1kt4A-1iiuA:31.6 | 1kt4A-1iiuA:79.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1KT4_A_RTLA184_0 (PLASMARETINOL-BINDINGPROTEIN) |
1iiu | PLASMARETINOL-BINDINGPROTEIN (Gallusgallus) | 6 / 12 | LEU A 37ALA A 57VAL A 61MET A 73GLN A 98HIS A 117 | RTL A 176 ( 4.5A)RTL A 176 ( 3.8A)NoneRTL A 176 ( 4.0A)RTL A 176 (-3.8A)RTL A 176 ( 4.6A) | 1.36A | 1kt4A-1iiuA:31.6 | 1kt4A-1iiuA:79.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1KT5_A_RTLA176_0 (PLASMARETINOL-BINDINGPROTEIN) |
1iiu | PLASMARETINOL-BINDINGPROTEIN (Gallusgallus) | 5 / 12 | ALA A 55ALA A 43MET A 88HIS A 104TYR A 133 | RTL A 176 ( 3.8A)RTL A 176 ( 4.1A)RTL A 176 (-3.4A)RTL A 176 ( 4.7A)None | 1.20A | 1kt5A-1iiuA:31.6 | 1kt5A-1iiuA:80.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1KT5_A_RTLA176_0 (PLASMARETINOL-BINDINGPROTEIN) |
1iiu | PLASMARETINOL-BINDINGPROTEIN (Gallusgallus) | 12 / 12 | LEU A 35LEU A 37PHE A 45ALA A 55ALA A 57MET A 73MET A 88TYR A 90LEU A 97HIS A 104ARG A 121TYR A 133 | RTL A 176 (-4.5A)RTL A 176 ( 4.5A)RTL A 176 ( 4.8A)RTL A 176 ( 3.8A)RTL A 176 ( 3.8A)RTL A 176 ( 4.0A)RTL A 176 (-3.4A)RTL A 176 ( 4.0A)RTL A 176 (-4.0A)RTL A 176 ( 4.7A)RTL A 176 ( 4.8A)None | 0.33A | 1kt5A-1iiuA:31.6 | 1kt5A-1iiuA:80.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1KT5_A_RTLA176_0 (PLASMARETINOL-BINDINGPROTEIN) |
1iiu | PLASMARETINOL-BINDINGPROTEIN (Gallusgallus) | 5 / 12 | LEU A 37ALA A 57MET A 73LEU A 97HIS A 117 | RTL A 176 ( 4.5A)RTL A 176 ( 3.8A)RTL A 176 ( 4.0A)RTL A 176 (-4.0A)RTL A 176 ( 4.6A) | 1.31A | 1kt5A-1iiuA:31.6 | 1kt5A-1iiuA:80.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1KT6_A_RTLA184_0 (PLASMARETINOL-BINDINGPROTEIN) |
1iiu | PLASMARETINOL-BINDINGPROTEIN (Gallusgallus) | 11 / 11 | LEU A 35LEU A 37ALA A 55VAL A 61MET A 73MET A 88TYR A 90LEU A 97GLN A 98HIS A 104ARG A 121 | RTL A 176 (-4.5A)RTL A 176 ( 4.5A)RTL A 176 ( 3.8A)NoneRTL A 176 ( 4.0A)RTL A 176 (-3.4A)RTL A 176 ( 4.0A)RTL A 176 (-4.0A)RTL A 176 (-3.8A)RTL A 176 ( 4.7A)RTL A 176 ( 4.8A) | 0.33A | 1kt6A-1iiuA:31.8 | 1kt6A-1iiuA:79.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1KT6_A_RTLA184_0 (PLASMARETINOL-BINDINGPROTEIN) |
1iiu | PLASMARETINOL-BINDINGPROTEIN (Gallusgallus) | 6 / 11 | LEU A 37VAL A 61MET A 73LEU A 97GLN A 98HIS A 117 | RTL A 176 ( 4.5A)NoneRTL A 176 ( 4.0A)RTL A 176 (-4.0A)RTL A 176 (-3.8A)RTL A 176 ( 4.6A) | 1.29A | 1kt6A-1iiuA:31.8 | 1kt6A-1iiuA:79.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1KT7_A_RTLA184_0 (PLASMARETINOL-BINDINGPROTEIN) |
1iiu | PLASMARETINOL-BINDINGPROTEIN (Gallusgallus) | 11 / 11 | LEU A 35LEU A 37ALA A 55VAL A 61MET A 73MET A 88TYR A 90LEU A 97GLN A 98HIS A 104ARG A 121 | RTL A 176 (-4.5A)RTL A 176 ( 4.5A)RTL A 176 ( 3.8A)NoneRTL A 176 ( 4.0A)RTL A 176 (-3.4A)RTL A 176 ( 4.0A)RTL A 176 (-4.0A)RTL A 176 (-3.8A)RTL A 176 ( 4.7A)RTL A 176 ( 4.8A) | 0.32A | 1kt7A-1iiuA:32.0 | 1kt7A-1iiuA:79.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1KT7_A_RTLA184_0 (PLASMARETINOL-BINDINGPROTEIN) |
1iiu | PLASMARETINOL-BINDINGPROTEIN (Gallusgallus) | 6 / 11 | LEU A 37VAL A 61MET A 73LEU A 97GLN A 98HIS A 117 | RTL A 176 ( 4.5A)NoneRTL A 176 ( 4.0A)RTL A 176 (-4.0A)RTL A 176 (-3.8A)RTL A 176 ( 4.6A) | 1.29A | 1kt7A-1iiuA:32.0 | 1kt7A-1iiuA:79.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1MX8_A_RTLA135_0 (CELLULARRETINOL-BINDINGPROTEIN I, HOLO) |
1mx8 | CELLULARRETINOL-BINDINGPROTEIN I, HOLO (Rattusnorvegicus) | 12 / 12 | PHE A 16TYR A 19LEU A 20ALA A 33LEU A 36PRO A 38THR A 53ARG A 58TYR A 60MET A 62PHE A 64ILE A 77 | RTL A 135 ( 4.6A)NoneRTL A 135 ( 4.7A)RTL A 135 ( 3.9A)RTL A 135 ( 4.6A)RTL A 135 ( 4.4A)RTL A 135 ( 4.3A)NoneRTL A 135 ( 4.6A)RTL A 135 (-2.9A)RTL A 135 ( 3.8A)RTL A 135 (-3.5A) | 0.00A | 1mx8A-1mx8A:28.4 | 1mx8A-1mx8A:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1Q23_A_FUAA702_1 (CHLORAMPHENICOLACETYLTRANSFERASE) |
1iiu | PLASMARETINOL-BINDINGPROTEIN (Gallusgallus) | 5 / 12 | PHE A 77LEU A 37VAL A 41PHE A 135ALA A 43 | NoneRTL A 176 ( 4.5A)NoneRTL A 176 ( 4.2A)RTL A 176 ( 4.1A) | 1.05A | 1q23A-1iiuA:undetectable1q23B-1iiuA:0.0 | 1q23A-1iiuA:21.101q23B-1iiuA:21.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1Q23_D_FUAD705_1 (CHLORAMPHENICOLACETYLTRANSFERASE) |
1iiu | PLASMARETINOL-BINDINGPROTEIN (Gallusgallus) | 5 / 12 | PHE A 77LEU A 37VAL A 41PHE A 135ALA A 43 | NoneRTL A 176 ( 4.5A)NoneRTL A 176 ( 4.2A)RTL A 176 ( 4.1A) | 1.00A | 1q23D-1iiuA:0.01q23E-1iiuA:undetectable | 1q23D-1iiuA:21.101q23E-1iiuA:21.10 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1QAB_E_RTLE1_0 (PROTEIN (RETINOLBINDING PROTEIN)) |
1iiu | PLASMARETINOL-BINDINGPROTEIN (Gallusgallus) | 5 / 11 | PHE A 36ALA A 43MET A 88HIS A 104TYR A 133 | NoneRTL A 176 ( 4.1A)RTL A 176 (-3.4A)RTL A 176 ( 4.7A)None | 1.14A | 1qabE-1iiuA:26.5 | 1qabE-1iiuA:84.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1QAB_E_RTLE1_0 (PROTEIN (RETINOLBINDING PROTEIN)) |
1iiu | PLASMARETINOL-BINDINGPROTEIN (Gallusgallus) | 11 / 11 | PHE A 36LEU A 37ALA A 57VAL A 61MET A 73MET A 88TYR A 90LEU A 97GLN A 98HIS A 104TYR A 133 | NoneRTL A 176 ( 4.5A)RTL A 176 ( 3.8A)NoneRTL A 176 ( 4.0A)RTL A 176 (-3.4A)RTL A 176 ( 4.0A)RTL A 176 (-4.0A)RTL A 176 (-3.8A)RTL A 176 ( 4.7A)None | 0.82A | 1qabE-1iiuA:26.5 | 1qabE-1iiuA:84.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1QAB_E_RTLE1_0 (PROTEIN (RETINOLBINDING PROTEIN)) |
1iiu | PLASMARETINOL-BINDINGPROTEIN (Gallusgallus) | 8 / 11 | PHE A 36LEU A 37VAL A 61MET A 73LEU A 97GLN A 98HIS A 117TYR A 133 | NoneRTL A 176 ( 4.5A)NoneRTL A 176 ( 4.0A)RTL A 176 (-4.0A)RTL A 176 (-3.8A)RTL A 176 ( 4.6A)None | 1.30A | 1qabE-1iiuA:26.5 | 1qabE-1iiuA:84.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1QAB_F_RTLF2_0 (PROTEIN (RETINOLBINDING PROTEIN)) |
1iiu | PLASMARETINOL-BINDINGPROTEIN (Gallusgallus) | 6 / 12 | PHE A 36ALA A 43LEU A 63MET A 73LEU A 97GLN A 98 | NoneRTL A 176 ( 4.1A)NoneRTL A 176 ( 4.0A)RTL A 176 (-4.0A)RTL A 176 (-3.8A) | 1.45A | 1qabF-1iiuA:28.7 | 1qabF-1iiuA:84.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1QAB_F_RTLF2_0 (PROTEIN (RETINOLBINDING PROTEIN)) |
1iiu | PLASMARETINOL-BINDINGPROTEIN (Gallusgallus) | 12 / 12 | PHE A 36ALA A 55ALA A 57LEU A 63MET A 73GLY A 75PHE A 77MET A 88TYR A 90LEU A 97GLN A 98HIS A 104 | NoneRTL A 176 ( 3.8A)RTL A 176 ( 3.8A)NoneRTL A 176 ( 4.0A)RTL A 176 ( 4.0A)NoneRTL A 176 (-3.4A)RTL A 176 ( 4.0A)RTL A 176 (-4.0A)RTL A 176 (-3.8A)RTL A 176 ( 4.7A) | 0.80A | 1qabF-1iiuA:28.7 | 1qabF-1iiuA:84.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1RBP_A_RTLA183_0 (PLASMARETINOL-BINDINGPROTEIN PRECURSOR) |
1iiu | PLASMARETINOL-BINDINGPROTEIN (Gallusgallus) | 12 / 12 | LEU A 35LEU A 37ALA A 43PHE A 45ALA A 55ALA A 57VAL A 61MET A 73MET A 88LEU A 97GLN A 98HIS A 104 | RTL A 176 (-4.5A)RTL A 176 ( 4.5A)RTL A 176 ( 4.1A)RTL A 176 ( 4.8A)RTL A 176 ( 3.8A)RTL A 176 ( 3.8A)NoneRTL A 176 ( 4.0A)RTL A 176 (-3.4A)RTL A 176 (-4.0A)RTL A 176 (-3.8A)RTL A 176 ( 4.7A) | 0.39A | 1rbpA-1iiuA:31.9 | 1rbpA-1iiuA:84.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1RBP_A_RTLA183_0 (PLASMARETINOL-BINDINGPROTEIN PRECURSOR) |
1iiu | PLASMARETINOL-BINDINGPROTEIN (Gallusgallus) | 5 / 12 | LEU A 35LEU A 37PHE A 77MET A 73LEU A 97 | RTL A 176 (-4.5A)RTL A 176 ( 4.5A)NoneRTL A 176 ( 4.0A)RTL A 176 (-4.0A) | 1.30A | 1rbpA-1iiuA:31.9 | 1rbpA-1iiuA:84.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1RLB_E_REAE176_1 (RETINOL BINDINGPROTEIN) |
1iiu | PLASMARETINOL-BINDINGPROTEIN (Gallusgallus) | 9 / 10 | LEU A 37ALA A 55ALA A 57VAL A 61MET A 73LEU A 97GLN A 98ASP A 102PHE A 135 | RTL A 176 ( 4.5A)RTL A 176 ( 3.8A)RTL A 176 ( 3.8A)NoneRTL A 176 ( 4.0A)RTL A 176 (-4.0A)RTL A 176 (-3.8A)NoneRTL A 176 ( 4.2A) | 0.62A | 1rlbE-1iiuA:30.8 | 1rlbE-1iiuA:80.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1RLB_F_REAF177_1 (RETINOL BINDINGPROTEIN) |
1iiu | PLASMARETINOL-BINDINGPROTEIN (Gallusgallus) | 10 / 11 | PHE A 36LEU A 37ALA A 55ALA A 57VAL A 61LEU A 63MET A 73MET A 88LEU A 97GLN A 98 | NoneRTL A 176 ( 4.5A)RTL A 176 ( 3.8A)RTL A 176 ( 3.8A)NoneNoneRTL A 176 ( 4.0A)RTL A 176 (-3.4A)RTL A 176 (-4.0A)RTL A 176 (-3.8A) | 0.65A | 1rlbF-1iiuA:30.5 | 1rlbF-1iiuA:80.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1RLB_F_REAF177_1 (RETINOL BINDINGPROTEIN) |
1iiu | PLASMARETINOL-BINDINGPROTEIN (Gallusgallus) | 10 / 11 | PHE A 36LEU A 37ALA A 55ALA A 57VAL A 61MET A 73MET A 88TYR A 90LEU A 97GLN A 98 | NoneRTL A 176 ( 4.5A)RTL A 176 ( 3.8A)RTL A 176 ( 3.8A)NoneRTL A 176 ( 4.0A)RTL A 176 (-3.4A)RTL A 176 ( 4.0A)RTL A 176 (-4.0A)RTL A 176 (-3.8A) | 0.54A | 1rlbF-1iiuA:30.5 | 1rlbF-1iiuA:80.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1X8V_A_ESLA472_1 (CYTOCHROME P450 51) |
1iiu | PLASMARETINOL-BINDINGPROTEIN (Gallusgallus) | 4 / 6 | MET A 73VAL A 93LEU A 97PHE A 96 | RTL A 176 ( 4.0A)NoneRTL A 176 (-4.0A)None | 1.15A | 1x8vA-1iiuA:0.0 | 1x8vA-1iiuA:15.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2F16_K_BO2K1402_1 (PROTEASOME COMPONENTPRE2PROTEASOME COMPONENTC5) |
1iiu | PLASMARETINOL-BINDINGPROTEIN (Gallusgallus) | 5 / 10 | ALA A 57THR A 56ALA A 55ALA A 43GLY A 92 | RTL A 176 ( 3.8A)NoneRTL A 176 ( 3.8A)RTL A 176 ( 4.1A)None | 0.87A | 2f16K-1iiuA:undetectable2f16L-1iiuA:undetectable | 2f16K-1iiuA:18.472f16L-1iiuA:21.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2F16_Y_BO2Y1403_1 (PROTEASOME COMPONENTPRE2PROTEASOME COMPONENTC5) |
1iiu | PLASMARETINOL-BINDINGPROTEIN (Gallusgallus) | 5 / 10 | ALA A 57THR A 56ALA A 55ALA A 43GLY A 92 | RTL A 176 ( 3.8A)NoneRTL A 176 ( 3.8A)RTL A 176 ( 4.1A)None | 0.87A | 2f16Y-1iiuA:undetectable2f16Z-1iiuA:undetectable | 2f16Y-1iiuA:18.472f16Z-1iiuA:21.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2FR3_A_REAA300_1 (CELLULAR RETINOICACID BINDING PROTEIN2) |
1mx8 | CELLULARRETINOL-BINDINGPROTEIN I, HOLO (Rattusnorvegicus) | 5 / 12 | PHE A 16LEU A 20ILE A 32ALA A 33THR A 53 | RTL A 135 ( 4.6A)RTL A 135 ( 4.7A)NoneRTL A 135 ( 3.9A)RTL A 135 ( 4.3A) | 0.87A | 2fr3A-1mx8A:16.5 | 2fr3A-1mx8A:44.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3BSZ_E_RTLE177_0 (PLASMARETINOL-BINDINGPROTEIN) |
1iiu | PLASMARETINOL-BINDINGPROTEIN (Gallusgallus) | 10 / 11 | LEU A 37ALA A 43ALA A 57VAL A 61MET A 73MET A 88LEU A 97GLN A 98HIS A 104PHE A 135 | RTL A 176 ( 4.5A)RTL A 176 ( 4.1A)RTL A 176 ( 3.8A)NoneRTL A 176 ( 4.0A)RTL A 176 (-3.4A)RTL A 176 (-4.0A)RTL A 176 (-3.8A)RTL A 176 ( 4.7A)RTL A 176 ( 4.2A) | 0.43A | 3bszE-1iiuA:30.1 | 3bszE-1iiuA:85.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3BSZ_E_RTLE177_0 (PLASMARETINOL-BINDINGPROTEIN) |
1iiu | PLASMARETINOL-BINDINGPROTEIN (Gallusgallus) | 7 / 11 | LEU A 37ALA A 57VAL A 61MET A 73LEU A 97GLN A 98HIS A 117 | RTL A 176 ( 4.5A)RTL A 176 ( 3.8A)NoneRTL A 176 ( 4.0A)RTL A 176 (-4.0A)RTL A 176 (-3.8A)RTL A 176 ( 4.6A) | 1.29A | 3bszE-1iiuA:30.1 | 3bszE-1iiuA:85.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3BSZ_F_RTLF178_0 (PLASMARETINOL-BINDINGPROTEIN) |
1iiu | PLASMARETINOL-BINDINGPROTEIN (Gallusgallus) | 5 / 11 | ALA A 57ALA A 55MET A 88HIS A 104PHE A 135 | RTL A 176 ( 3.8A)RTL A 176 ( 3.8A)RTL A 176 (-3.4A)RTL A 176 ( 4.7A)RTL A 176 ( 4.2A) | 1.34A | 3bszF-1iiuA:30.0 | 3bszF-1iiuA:85.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3BSZ_F_RTLF178_0 (PLASMARETINOL-BINDINGPROTEIN) |
1iiu | PLASMARETINOL-BINDINGPROTEIN (Gallusgallus) | 10 / 11 | LEU A 37ALA A 43PHE A 45ALA A 55MET A 73MET A 88TYR A 90GLN A 98HIS A 104PHE A 135 | RTL A 176 ( 4.5A)RTL A 176 ( 4.1A)RTL A 176 ( 4.8A)RTL A 176 ( 3.8A)RTL A 176 ( 4.0A)RTL A 176 (-3.4A)RTL A 176 ( 4.0A)RTL A 176 (-3.8A)RTL A 176 ( 4.7A)RTL A 176 ( 4.2A) | 0.40A | 3bszF-1iiuA:30.0 | 3bszF-1iiuA:85.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3MG0_Y_BO2Y1403_1 (PROTEASOME COMPONENTPRE2PROTEASOME COMPONENTC5) |
1iiu | PLASMARETINOL-BINDINGPROTEIN (Gallusgallus) | 5 / 12 | ALA A 57THR A 56ALA A 55ALA A 43GLY A 92 | RTL A 176 ( 3.8A)NoneRTL A 176 ( 3.8A)RTL A 176 ( 4.1A)None | 0.87A | 3mg0Y-1iiuA:0.93mg0Z-1iiuA:0.0 | 3mg0Y-1iiuA:18.473mg0Z-1iiuA:21.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OGP_A_017A200_2 (FIV PROTEASE) |
1iiu | PLASMARETINOL-BINDINGPROTEIN (Gallusgallus) | 5 / 10 | VAL A 61GLY A 92ILE A 74VAL A 41LEU A 37 | NoneNoneNoneNoneRTL A 176 ( 4.5A) | 0.73A | 3ogpB-1iiuA:undetectable | 3ogpB-1iiuA:21.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4DF3_A_SAMA301_1 (FIBRILLARIN-LIKERRNA/TRNA2'-O-METHYLTRANSFERASE) |
1fml | RETINOL DEHYDRATASE (Spodopterafrugiperda) | 3 / 3 | TYR A 120THR A 33GLU A 118 | RTL A 401 ( 4.5A)NoneNone | 0.75A | 4df3A-1fmlA:0.7 | 4df3A-1fmlA:21.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4DF3_B_SAMB301_1 (FIBRILLARIN-LIKERRNA/TRNA2'-O-METHYLTRANSFERASE) |
1fml | RETINOL DEHYDRATASE (Spodopterafrugiperda) | 3 / 3 | TYR A 120THR A 33GLU A 118 | RTL A 401 ( 4.5A)NoneNone | 0.76A | 4df3B-1fmlA:0.7 | 4df3B-1fmlA:21.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4KOV_A_KOVA204_1 (UNCHARACTERIZEDPROTEIN) |
1fml | RETINOL DEHYDRATASE (Spodopterafrugiperda) | 5 / 12 | TYR A 141TYR A 105GLY A 108TYR A 46LEU A 201 | NoneRTL A 401 (-4.6A)NoneNoneRTL A 401 ( 4.3A) | 1.48A | 4kovA-1fmlA:0.0 | 4kovA-1fmlA:18.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5H8T_A_RTLA201_0 (RETINOL-BINDINGPROTEIN 1) |
1mx8 | CELLULARRETINOL-BINDINGPROTEIN I, HOLO (Rattusnorvegicus) | 6 / 12 | LEU A 23ILE A 51ARG A 58TYR A 60MET A 62ILE A 77 | NoneRTL A 135 ( 4.6A)NoneRTL A 135 ( 4.6A)RTL A 135 (-2.9A)RTL A 135 (-3.5A) | 1.49A | 5h8tA-1mx8A:20.1 | 5h8tA-1mx8A:92.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5H8T_A_RTLA201_0 (RETINOL-BINDINGPROTEIN 1) |
1mx8 | CELLULARRETINOL-BINDINGPROTEIN I, HOLO (Rattusnorvegicus) | 10 / 12 | PHE A 16TYR A 19LEU A 20LEU A 29ALA A 33ILE A 51SER A 55ARG A 58MET A 62ILE A 77 | RTL A 135 ( 4.6A)NoneRTL A 135 ( 4.7A)RTL A 135 (-3.8A)RTL A 135 ( 3.9A)RTL A 135 ( 4.6A)RTL A 135 ( 4.4A)NoneRTL A 135 (-2.9A)RTL A 135 (-3.5A) | 1.00A | 5h8tA-1mx8A:20.1 | 5h8tA-1mx8A:92.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5H8T_A_RTLA201_0 (RETINOL-BINDINGPROTEIN 1) |
1mx8 | CELLULARRETINOL-BINDINGPROTEIN I, HOLO (Rattusnorvegicus) | 10 / 12 | PHE A 16TYR A 19LEU A 29ALA A 33ILE A 51SER A 55ARG A 58TYR A 60MET A 62ILE A 77 | RTL A 135 ( 4.6A)NoneRTL A 135 (-3.8A)RTL A 135 ( 3.9A)RTL A 135 ( 4.6A)RTL A 135 ( 4.4A)NoneRTL A 135 ( 4.6A)RTL A 135 (-2.9A)RTL A 135 (-3.5A) | 1.00A | 5h8tA-1mx8A:20.1 | 5h8tA-1mx8A:92.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HBS_A_RTLA201_0 (RETINOL-BINDINGPROTEIN 1) |
1mx8 | CELLULARRETINOL-BINDINGPROTEIN I, HOLO (Rattusnorvegicus) | 8 / 12 | PHE A 16TYR A 19ALA A 33ILE A 51SER A 55ARG A 58MET A 62ILE A 77 | RTL A 135 ( 4.6A)NoneRTL A 135 ( 3.9A)RTL A 135 ( 4.6A)RTL A 135 ( 4.4A)NoneRTL A 135 (-2.9A)RTL A 135 (-3.5A) | 0.92A | 5hbsA-1mx8A:19.9 | 5hbsA-1mx8A:92.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HBS_A_RTLA201_0 (RETINOL-BINDINGPROTEIN 1) |
1mx8 | CELLULARRETINOL-BINDINGPROTEIN I, HOLO (Rattusnorvegicus) | 8 / 12 | PHE A 16TYR A 19ALA A 33PRO A 38ILE A 51ARG A 58MET A 62ILE A 77 | RTL A 135 ( 4.6A)NoneRTL A 135 ( 3.9A)RTL A 135 ( 4.4A)RTL A 135 ( 4.6A)NoneRTL A 135 (-2.9A)RTL A 135 (-3.5A) | 0.95A | 5hbsA-1mx8A:19.9 | 5hbsA-1mx8A:92.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HBS_A_RTLA201_0 (RETINOL-BINDINGPROTEIN 1) |
1mx8 | CELLULARRETINOL-BINDINGPROTEIN I, HOLO (Rattusnorvegicus) | 8 / 12 | PHE A 16TYR A 19LEU A 29ALA A 33ILE A 51SER A 55MET A 62ILE A 77 | RTL A 135 ( 4.6A)NoneRTL A 135 (-3.8A)RTL A 135 ( 3.9A)RTL A 135 ( 4.6A)RTL A 135 ( 4.4A)RTL A 135 (-2.9A)RTL A 135 (-3.5A) | 0.92A | 5hbsA-1mx8A:19.9 | 5hbsA-1mx8A:92.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HBS_A_RTLA201_0 (RETINOL-BINDINGPROTEIN 1) |
1mx8 | CELLULARRETINOL-BINDINGPROTEIN I, HOLO (Rattusnorvegicus) | 8 / 12 | PHE A 16TYR A 19LEU A 29ALA A 33PRO A 38ILE A 51MET A 62ILE A 77 | RTL A 135 ( 4.6A)NoneRTL A 135 (-3.8A)RTL A 135 ( 3.9A)RTL A 135 ( 4.4A)RTL A 135 ( 4.6A)RTL A 135 (-2.9A)RTL A 135 (-3.5A) | 0.96A | 5hbsA-1mx8A:19.9 | 5hbsA-1mx8A:92.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HBS_A_RTLA201_0 (RETINOL-BINDINGPROTEIN 1) |
1mx8 | CELLULARRETINOL-BINDINGPROTEIN I, HOLO (Rattusnorvegicus) | 8 / 12 | PHE A 16TYR A 19VAL A 25LEU A 29ALA A 33ILE A 51SER A 55ILE A 77 | RTL A 135 ( 4.6A)NoneNoneRTL A 135 (-3.8A)RTL A 135 ( 3.9A)RTL A 135 ( 4.6A)RTL A 135 ( 4.4A)RTL A 135 (-3.5A) | 0.86A | 5hbsA-1mx8A:19.9 | 5hbsA-1mx8A:92.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HBS_A_RTLA201_0 (RETINOL-BINDINGPROTEIN 1) |
1mx8 | CELLULARRETINOL-BINDINGPROTEIN I, HOLO (Rattusnorvegicus) | 8 / 12 | PHE A 16TYR A 19VAL A 25LEU A 29ALA A 33PRO A 38ILE A 51ILE A 77 | RTL A 135 ( 4.6A)NoneNoneRTL A 135 (-3.8A)RTL A 135 ( 3.9A)RTL A 135 ( 4.4A)RTL A 135 ( 4.6A)RTL A 135 (-3.5A) | 0.88A | 5hbsA-1mx8A:19.9 | 5hbsA-1mx8A:92.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HBS_A_RTLA201_0 (RETINOL-BINDINGPROTEIN 1) |
1mx8 | CELLULARRETINOL-BINDINGPROTEIN I, HOLO (Rattusnorvegicus) | 6 / 12 | VAL A 25LEU A 29ALA A 33PRO A 38ILE A 61ILE A 77 | NoneRTL A 135 (-3.8A)RTL A 135 ( 3.9A)RTL A 135 ( 4.4A)NoneRTL A 135 (-3.5A) | 1.33A | 5hbsA-1mx8A:19.9 | 5hbsA-1mx8A:92.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5L5Z_K_BO2K301_1 (PROTEASOME SUBUNITBETATYPE-5,PROTEASOMESUBUNIT BETA TYPE-5PROTEASOME SUBUNITBETATYPE-6,PROTEASOMESUBUNIT BETATYPE-1,PROTEASOMESUBUNIT BETATYPE-6,PROTEASOMESUBUNIT BETATYPE-1,PROTEASOMESUBUNIT BETA TYPE-6) |
1iiu | PLASMARETINOL-BINDINGPROTEIN (Gallusgallus) | 5 / 9 | ALA A 57THR A 56ALA A 55ALA A 43GLY A 92 | RTL A 176 ( 3.8A)NoneRTL A 176 ( 3.8A)RTL A 176 ( 4.1A)None | 0.85A | 5l5zK-1iiuA:undetectable5l5zL-1iiuA:undetectable | 5l5zK-1iiuA:19.005l5zL-1iiuA:21.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5L5Z_Y_BO2Y301_1 (PROTEASOME SUBUNITBETATYPE-5,PROTEASOMESUBUNIT BETA TYPE-5PROTEASOME SUBUNITBETATYPE-6,PROTEASOMESUBUNIT BETATYPE-1,PROTEASOMESUBUNIT BETATYPE-6,PROTEASOMESUBUNIT BETATYPE-1,PROTEASOMESUBUNIT BETA TYPE-6) |
1iiu | PLASMARETINOL-BINDINGPROTEIN (Gallusgallus) | 5 / 9 | ALA A 57THR A 56ALA A 55ALA A 43GLY A 92 | RTL A 176 ( 3.8A)NoneRTL A 176 ( 3.8A)RTL A 176 ( 4.1A)None | 0.85A | 5l5zY-1iiuA:undetectable5l5zZ-1iiuA:undetectable | 5l5zY-1iiuA:19.005l5zZ-1iiuA:21.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5LJB_A_RTLA201_0 (RETINOL-BINDINGPROTEIN 1) |
1mx8 | CELLULARRETINOL-BINDINGPROTEIN I, HOLO (Rattusnorvegicus) | 7 / 12 | PHE A 16LEU A 29ALA A 33PRO A 38ARG A 58TYR A 60ILE A 77 | RTL A 135 ( 4.6A)RTL A 135 (-3.8A)RTL A 135 ( 3.9A)RTL A 135 ( 4.4A)NoneRTL A 135 ( 4.6A)RTL A 135 (-3.5A) | 0.88A | 5ljbA-1mx8A:19.7 | 5ljbA-1mx8A:96.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5LJB_A_RTLA201_0 (RETINOL-BINDINGPROTEIN 1) |
1mx8 | CELLULARRETINOL-BINDINGPROTEIN I, HOLO (Rattusnorvegicus) | 7 / 12 | PHE A 16LEU A 29ALA A 33PRO A 38TYR A 60MET A 62ILE A 77 | RTL A 135 ( 4.6A)RTL A 135 (-3.8A)RTL A 135 ( 3.9A)RTL A 135 ( 4.4A)RTL A 135 ( 4.6A)RTL A 135 (-2.9A)RTL A 135 (-3.5A) | 0.88A | 5ljbA-1mx8A:19.7 | 5ljbA-1mx8A:96.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5LJB_A_RTLA201_0 (RETINOL-BINDINGPROTEIN 1) |
1mx8 | CELLULARRETINOL-BINDINGPROTEIN I, HOLO (Rattusnorvegicus) | 7 / 12 | PHE A 16LEU A 29ALA A 33SER A 55TYR A 60MET A 62ILE A 77 | RTL A 135 ( 4.6A)RTL A 135 (-3.8A)RTL A 135 ( 3.9A)RTL A 135 ( 4.4A)RTL A 135 ( 4.6A)RTL A 135 (-2.9A)RTL A 135 (-3.5A) | 0.94A | 5ljbA-1mx8A:19.7 | 5ljbA-1mx8A:96.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5LJB_A_RTLA201_0 (RETINOL-BINDINGPROTEIN 1) |
1mx8 | CELLULARRETINOL-BINDINGPROTEIN I, HOLO (Rattusnorvegicus) | 6 / 12 | PHE A 16TYR A 19ALA A 33SER A 55PHE A 57MET A 62 | RTL A 135 ( 4.6A)NoneRTL A 135 ( 3.9A)RTL A 135 ( 4.4A)NoneRTL A 135 (-2.9A) | 1.23A | 5ljbA-1mx8A:19.7 | 5ljbA-1mx8A:96.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5LJB_A_RTLA201_0 (RETINOL-BINDINGPROTEIN 1) |
1mx8 | CELLULARRETINOL-BINDINGPROTEIN I, HOLO (Rattusnorvegicus) | 7 / 12 | PHE A 16TYR A 19LEU A 29ALA A 33PRO A 38ARG A 58ILE A 77 | RTL A 135 ( 4.6A)NoneRTL A 135 (-3.8A)RTL A 135 ( 3.9A)RTL A 135 ( 4.4A)NoneRTL A 135 (-3.5A) | 0.83A | 5ljbA-1mx8A:19.7 | 5ljbA-1mx8A:96.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5LJB_A_RTLA201_0 (RETINOL-BINDINGPROTEIN 1) |
1mx8 | CELLULARRETINOL-BINDINGPROTEIN I, HOLO (Rattusnorvegicus) | 7 / 12 | PHE A 16TYR A 19LEU A 29ALA A 33PRO A 38MET A 62ILE A 77 | RTL A 135 ( 4.6A)NoneRTL A 135 (-3.8A)RTL A 135 ( 3.9A)RTL A 135 ( 4.4A)RTL A 135 (-2.9A)RTL A 135 (-3.5A) | 0.94A | 5ljbA-1mx8A:19.7 | 5ljbA-1mx8A:96.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5LJB_A_RTLA201_0 (RETINOL-BINDINGPROTEIN 1) |
1mx8 | CELLULARRETINOL-BINDINGPROTEIN I, HOLO (Rattusnorvegicus) | 7 / 12 | PHE A 16TYR A 19LEU A 29ALA A 33SER A 55MET A 62ILE A 77 | RTL A 135 ( 4.6A)NoneRTL A 135 (-3.8A)RTL A 135 ( 3.9A)RTL A 135 ( 4.4A)RTL A 135 (-2.9A)RTL A 135 (-3.5A) | 0.95A | 5ljbA-1mx8A:19.7 | 5ljbA-1mx8A:96.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5LJB_A_RTLA201_1 (RETINOL-BINDINGPROTEIN 1) |
1mx8 | CELLULARRETINOL-BINDINGPROTEIN I, HOLO (Rattusnorvegicus) | 4 / 8 | LEU A 20LEU A 36LYS A 40ILE A 51 | RTL A 135 ( 4.7A)RTL A 135 ( 4.6A)RTL A 135 ( 4.4A)RTL A 135 ( 4.6A) | 0.85A | 5ljbA-1mx8A:19.7 | 5ljbA-1mx8A:96.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5LJC_A_RTLA201_0 (RETINOL-BINDINGPROTEIN 1) |
1mx8 | CELLULARRETINOL-BINDINGPROTEIN I, HOLO (Rattusnorvegicus) | 5 / 12 | PHE A 16TYR A 19ALA A 33SER A 55PHE A 57 | RTL A 135 ( 4.6A)NoneRTL A 135 ( 3.9A)RTL A 135 ( 4.4A)None | 1.21A | 5ljcA-1mx8A:19.7 | 5ljcA-1mx8A:95.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5LJC_A_RTLA201_0 (RETINOL-BINDINGPROTEIN 1) |
1mx8 | CELLULARRETINOL-BINDINGPROTEIN I, HOLO (Rattusnorvegicus) | 9 / 12 | PHE A 16TYR A 19LEU A 29ALA A 33LEU A 36PRO A 38ARG A 58TYR A 60ILE A 77 | RTL A 135 ( 4.6A)NoneRTL A 135 (-3.8A)RTL A 135 ( 3.9A)RTL A 135 ( 4.6A)RTL A 135 ( 4.4A)NoneRTL A 135 ( 4.6A)RTL A 135 (-3.5A) | 0.89A | 5ljcA-1mx8A:19.7 | 5ljcA-1mx8A:95.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5LJC_A_RTLA201_0 (RETINOL-BINDINGPROTEIN 1) |
1mx8 | CELLULARRETINOL-BINDINGPROTEIN I, HOLO (Rattusnorvegicus) | 8 / 12 | PHE A 16TYR A 19LEU A 29ALA A 33LEU A 36SER A 55TYR A 60ILE A 77 | RTL A 135 ( 4.6A)NoneRTL A 135 (-3.8A)RTL A 135 ( 3.9A)RTL A 135 ( 4.6A)RTL A 135 ( 4.4A)RTL A 135 ( 4.6A)RTL A 135 (-3.5A) | 0.94A | 5ljcA-1mx8A:19.7 | 5ljcA-1mx8A:95.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5LJE_A_RTLA201_0 (RETINOL-BINDINGPROTEIN 1) |
1mx8 | CELLULARRETINOL-BINDINGPROTEIN I, HOLO (Rattusnorvegicus) | 6 / 12 | PHE A 16LEU A 20LEU A 29ALA A 33PRO A 38ARG A 58 | RTL A 135 ( 4.6A)RTL A 135 ( 4.7A)RTL A 135 (-3.8A)RTL A 135 ( 3.9A)RTL A 135 ( 4.4A)None | 0.88A | 5ljeA-1mx8A:19.8 | 5ljeA-1mx8A:94.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5LJE_A_RTLA201_0 (RETINOL-BINDINGPROTEIN 1) |
1mx8 | CELLULARRETINOL-BINDINGPROTEIN I, HOLO (Rattusnorvegicus) | 6 / 12 | PHE A 16LEU A 20LEU A 29ALA A 33SER A 55ARG A 58 | RTL A 135 ( 4.6A)RTL A 135 ( 4.7A)RTL A 135 (-3.8A)RTL A 135 ( 3.9A)RTL A 135 ( 4.4A)None | 0.79A | 5ljeA-1mx8A:19.8 | 5ljeA-1mx8A:94.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5LJE_A_RTLA201_0 (RETINOL-BINDINGPROTEIN 1) |
1mx8 | CELLULARRETINOL-BINDINGPROTEIN I, HOLO (Rattusnorvegicus) | 7 / 12 | PHE A 16LEU A 29ALA A 33PRO A 38ARG A 58TYR A 60ILE A 77 | RTL A 135 ( 4.6A)RTL A 135 (-3.8A)RTL A 135 ( 3.9A)RTL A 135 ( 4.4A)NoneRTL A 135 ( 4.6A)RTL A 135 (-3.5A) | 0.82A | 5ljeA-1mx8A:19.8 | 5ljeA-1mx8A:94.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5LJE_A_RTLA201_0 (RETINOL-BINDINGPROTEIN 1) |
1mx8 | CELLULARRETINOL-BINDINGPROTEIN I, HOLO (Rattusnorvegicus) | 7 / 12 | PHE A 16LEU A 29ALA A 33SER A 55ARG A 58TYR A 60ILE A 77 | RTL A 135 ( 4.6A)RTL A 135 (-3.8A)RTL A 135 ( 3.9A)RTL A 135 ( 4.4A)NoneRTL A 135 ( 4.6A)RTL A 135 (-3.5A) | 0.86A | 5ljeA-1mx8A:19.8 | 5ljeA-1mx8A:94.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5LJE_A_RTLA201_1 (RETINOL-BINDINGPROTEIN 1) |
1mx8 | CELLULARRETINOL-BINDINGPROTEIN I, HOLO (Rattusnorvegicus) | 4 / 6 | LEU A 36ILE A 51THR A 53MET A 62 | RTL A 135 ( 4.6A)RTL A 135 ( 4.6A)RTL A 135 ( 4.3A)RTL A 135 (-2.9A) | 0.86A | 5ljeA-1mx8A:19.8 | 5ljeA-1mx8A:94.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5NU7_A_RTLA201_0 (RETINOL-BINDINGPROTEIN 4) |
1iiu | PLASMARETINOL-BINDINGPROTEIN (Gallusgallus) | 8 / 8 | LEU A 37ALA A 55VAL A 61MET A 73MET A 88TYR A 90GLN A 98HIS A 104 | RTL A 176 ( 4.5A)RTL A 176 ( 3.8A)NoneRTL A 176 ( 4.0A)RTL A 176 (-3.4A)RTL A 176 ( 4.0A)RTL A 176 (-3.8A)RTL A 176 ( 4.7A) | 0.36A | 5nu7A-1iiuA:31.7 | 5nu7A-1iiuA:84.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5NU7_A_RTLA201_0 (RETINOL-BINDINGPROTEIN 4) |
1iiu | PLASMARETINOL-BINDINGPROTEIN (Gallusgallus) | 5 / 8 | LEU A 37VAL A 61MET A 73GLN A 98HIS A 117 | RTL A 176 ( 4.5A)NoneRTL A 176 ( 4.0A)RTL A 176 (-3.8A)RTL A 176 ( 4.6A) | 1.31A | 5nu7A-1iiuA:31.7 | 5nu7A-1iiuA:84.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6HWD_K_BO2K301_0 (PROTEASOME SUBUNITBETA TYPE-5PROTEASOME SUBUNITBETA TYPE-6) |
1iiu | PLASMARETINOL-BINDINGPROTEIN (Gallusgallus) | 5 / 11 | ALA A 57THR A 56ALA A 55ALA A 43GLY A 92 | RTL A 176 ( 3.8A)NoneRTL A 176 ( 3.8A)RTL A 176 ( 4.1A)None | 0.87A | 6hwdK-1iiuA:undetectable6hwdL-1iiuA:undetectable | 6hwdK-1iiuA:18.976hwdL-1iiuA:19.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6HWD_Y_BO2Y301_0 (PROTEASOME SUBUNITBETA TYPE-5PROTEASOME SUBUNITBETA TYPE-6) |
1iiu | PLASMARETINOL-BINDINGPROTEIN (Gallusgallus) | 5 / 11 | ALA A 57THR A 56ALA A 55ALA A 43GLY A 92 | RTL A 176 ( 3.8A)NoneRTL A 176 ( 3.8A)RTL A 176 ( 4.1A)None | 0.87A | 6hwdY-1iiuA:undetectable6hwdZ-1iiuA:undetectable | 6hwdY-1iiuA:18.976hwdZ-1iiuA:19.41 |